Coronavirus disease 2019 (COVID-19): current status and future perspectives
Top Cited Papers
- 29 March 2020
- journal article
- research article
- Published by Elsevier BV in International Journal of Antimicrobial Agents
- Vol. 55 (5), 105951
- https://doi.org/10.1016/j.ijantimicag.2020.105951
Abstract
No abstract availableKeywords
This publication has 111 references indexed in Scilit:
- Anti-malaria drug chloroquine is highly effective in treating avian influenza A H5N1 virus infection in an animal modelCell Research, 2012
- Mesenchymal stem cells for acute lung injury: Preclinical evidenceCritical Care Medicine, 2010
- Human Umbilical Cord Mesenchymal Stem Cells Reduce Fibrosis of Bleomycin-Induced Lung InjuryThe American Journal of Pathology, 2009
- Incubation periods of acute respiratory viral infections: a systematic reviewThe Lancet Infectious Diseases, 2009
- Lopinavir-ritonavir monotherapy versus lopinavir-ritonavir and two nucleosides for maintenance therapy of HIVAIDS, 2008
- Interleukin 1 receptor antagonist mediates the antiinflammatory and antifibrotic effect of mesenchymal stem cells during lung injuryProceedings of the National Academy of Sciences of the United States of America, 2007
- Human Monoclonal Antibody Combination against SARS Coronavirus: Synergy and Coverage of Escape MutantsPLoS Medicine, 2006
- Characterization of the antiviral effects of interferon-α against a SARS-like coronoavirus infection in vitroCell Research, 2006
- Use of convalescent plasma therapy in SARS patients in Hong KongEuropean Journal of Clinical Microbiology & Infectious Diseases, 2004
- An efficient method to make human monoclonal antibodies from memory B cells: potent neutralization of SARS coronavirusNature Medicine, 2004